연구
-
-
연구
-
연구업적
연구업적
최근 5년 연구업적 현황
| 연도 | 2024년 | 2023년 | 2022년 | 2021년 | 2020년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 179편 | 173편 | 163편 | 184편 | 135편 |
| 공동 | 147편 | 120편 | 115편 | 136편 | 168편 | |
| 합계 | 326편 | 293편 | 278편 | 320편 | 303편 | |
487. Optimization of patient selection for gefitinib in non-small cell lung cancer by combined analysis of epidermal growth factor receptor mutation, K-ras mutation, and Akt phosphorylation.
Han SW, Kim TY, Jeon YK, Hwang PG, Im SA, Lee KH, Kim JH, Kim DW, Heo DS, Kim NK, Chung DH, Bang YJ.
Clin Cancer Res. 2006 Apr 15;12(8):2538-44.
Link
486. Primary systemic anaplastic large cell lymphoma in a single Korean institution: clinical characteristics and treatment outcome.
Park SR, Baek JY, Kim DW, Im SA, Kim TY, Bang YJ, Kim NK, Jeon YK, Kim CW, Heo DS.
J Korean Med Sci. 2006 Aug;21(4):633-8.
Link
485. Histone deacetylase inhibitor enhances 5-fluorouracil cytotoxicity by down-regulating thymidylate synthase in human cancer cells.
Lee JH, Park JH, Jung Y, Kim JH, Jong HS, Kim TY, Bang YJ.
Mol Cancer Ther. 2006 Dec;5(12):3085-95.
Link
484. Clinical predictors versus epidermal growth factor receptor mutation in gefitinib-treated non-small-cell lung cancer patients.
Han, S. W. Kim, T. Y. Lee, K. H. Hwang, P. G. Jeon, Y. K. Oh, D. Y. Lee, S. H. Kim, D. W. Im, S. A. Chung, D. H. Heo, D. S. Bang, Y. J.
Lung Cancer 2006; 54:201-207.
Link
483. Human papillomavirus 16 E5 up-regulates the expression of vascular endothelial growth factor through the activation of epidermal growth factor receptor, MEK/ ERK1,2 and PI3K/Akt.
Kim, S. H. Juhnn, Y. S. Kang, S. Park, S. W. Sung, M. W. Bang, Y. J. Song, Y. S.
Cellular and Molcular Life Science 2006; 63(7-8):930-938.
Link
482. Synchronous gastric cancer in primary sporadic colorectal cancer patients in Korea.
Lim SB, Jeong SY, Choi HS, Sohn DK, Hong CW, Jung KH, Chang HJ, Park JG, Choi IJ, Kim CG.
Int J Colorectal Dis. 2008 Jan;23(1):61-5
Link
481. Hereditary nonpolyposis colorectal cancer in endometrial cancer patients.
Yoon SN, Ku JL, Shin YK, Kim KH, Choi JS, Jang EJ, Park HC, Kim DW, Kim MA, Kim WH, Lee TS, Kim JW, Park NH, Song YS, Kang SB, Lee HP, Jeong SY, Park JG.
Int J Cancer. 2008 Mar 1;122(5):1077-81.
Link
480. International Society for Gastrointestinal Hereditary Tumours. Germ LineMutations ofMismatch Repair Genes in Hereditary Nonpolyposis Colorectal Cancer Patients with Small Bowel Cancer: International Society for Gastrointestinal HereditaryTumours Collaborative Study.
Park JG, Kim DW, Hong CW, Nam BH, Shin YK, Hong SH, Kim IJ, Lim SB, Aronson M, Bisgaard ML, Brown GJ, Burn J, Chow E, Conrad P, Douglas F, Dunlop M, Ford J, Greenblatt MS, Heikki J, Heinimann K, Lynch EL, Macrae F, McKinnon WC, Moeslein G, Rossi BM, Rozen P, Schofield L, Vaccaro C, Vasen H, Velthuizen M, Viel A, Wijnen J;
Clinical Cancer Research . 2006, 12(11), 3389-3393
Link
479. Analysis of microsatellite instability in stool DNA of patients with colorectal cancer using denaturing high performance liquid chromatography.
Lim SB, Jeong SY, Kim IJ, Kim DY, Jung KH, Chang HJ, Choi HS, Sohn DK, Kang HC, Shin Y, Jang SG, Park JH, Park JG.
World Journal of Gastrenterology. 2006, 7, 14(41), 6689-6692
Link
478. Correlation between hypermethylation of the RASSF2A promoter and K-ras/BRAF mutations in microsatellite-stable colorectal cancers.
Hye-Won Park, Hio Chung Kang, Il-Jin Kim, Sang-Geun Jang, Kun Kim, Hyun-Ju Yoon, Seung-Yong Jeong, Jae-Gahb Park.
International Journal of Cancer. 2006, 120, 7-12 (In press)
Link